This unique dermatological solution is the product of Caregen, a progressive skin biology company located in South Korea. With a strong focus on research and development, Caregen has a firm commitment to the creation of innovative, science-based cosmeceutical and pharmaceutical products.
Each package of Revofil Aquashine BR contains a 32G½” needle and 1 prefilled 2mL syringe of a 15mg/mL hyaluronic acid solution.
WHAT IS IT USED FOR?
Revofil Aquashine BR is indicated for boosting skin’s hydration, elasticity, and smoothness; brightening the complexion; and reducing wrinkles and fine lines. It also helps to shrink pores and prevent further skin damage on the decolletage area, face, and neck.
HOW DOES THIS DERMAL FILLER WORK?
The bioactive compounds present in Revofil Aquashine BR work to improve skin quality at a cellular level via injection into the superficial to mid dermis. Filled with hyaluronic acid, coenzymes, minerals, vitamins, peptides, and amino acids, this unique filler provides a multi-tiered approach to restorative skincare.
In this formula, non-crosslinked hyaluronic acid works to increase skin’s moisture at the cellular level. This helps to improve skin’s overall texture whilst also adding volume, reducing the appearance of wrinkles and fine lines. What’s more, hyaluronic acid is known to have antioxidant effects, protecting the skin from further damage by warding off free radicals.
Generally, non-crosslinked hyaluronic acid breaks down quickly within the body. However, in Revofil Aquashine BR, peptides work to block hyaluronidase production, increasing the hyaluronic acid’s longevity.
Additionally, amino acids, minerals, vitamins, and coenzymes work to nourish the skin, improving its overall elasticity and texture while encouraging the growth of new skin cells. Moreover, these elements help to reduce melanin synthesis, which assists in the diminishing of uneven skin tone and hyperpigmentation.
HOW TO INJECT
Only certified medical practitioners may perform injections with Revofil Aquashine BR. Additionally, injectors should be trained in proper injection techniques. This will help to ensure patient safety, reducing the chances of unwanted complications both during and after treatment.
Prior to treatment, the patient must be questioned about his or her medical history and informed about the foreseeable outcome of Revofil Aquashine BR use. The skin must also be disinfected and prepared for treatment via aseptic clinical practice guidelines.
This dermal filler may be injected into the skin using manual injection techniques or an injection gun. Product should be injected into the superficial to mid dermis of the face, neck, or decolletage area using either a serial puncture or nappage technique.
Initially, this injectable filler should be given in 3 sessions at 4-week intervals. Then, 2 to 3 sessions are recommended per year to maintain the original effects of the treatment. However, depending on the severity of the patient’s needs, 6 initial treatments at 2-week intervals may be necessary, followed by 5–6 yearly top-up sessions.
After treatment, ensure that all used needles and remaining product have been properly disposed of. For further information on the injection process, consult the pamphlet provided in the product packaging.
HOW LONG DOES THIS FACIAL FILLER LAST?
Note that the longevity of Revofil Aquashine BR injections will vary based on the patient’s age, skin type, and lifestyle. However, its effects generally last between 2 and 6 months.
